Immune Privilege Within: Regulatory T Cells Tip the Balance in Favor of Lymph Node Metastasis
Kahn and colleagues reveal that lymph nodes (LN) provide an intrinsically immunosuppressive niche that prevents effector function of activated CD8+ T cells in LNs and allows immunogenic tumor cells to survive and drive cancer progression, independent of tumor-derived preconditioning. By locally suppressing IL2 availability, regulatory T cells in LNs impair CD8+ T-cell cytotoxicity-a mechanism with important implications for immune checkpoint therapy and LN-targeted immunomodulation. See related article by Kahn et al., p. 1949.
Authors
- Lutz Menzel (ORCID: https://orcid.org/0000-0002-3816-6255)
- Timothy P. Padera (ORCID: https://orcid.org/0000-0002-3453-9384)
Institutions
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Cancer Discovery
- Published
- 2025-09-04
- DOI
- https://doi.org/10.1158/2159-8290.cd-25-1043
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00